GLP-1 drugs: what TennCare paid

Q: Does a paid prescription mean TennCare covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

TennCare shows a published payment figure for 8 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read TennCare's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What TennCare’s payment record shows

In 2026Q1, the product TennCare paid for most often was Wegovy®, at 19,383 prescriptions¹³ of the 62,284 to 62,401^{1,7,13,19,25,31,37,43} across all 8 products, or 31 percent of the published count.

TennCare itself reimbursed at least $69,564,960 for these products in the quarter, about $1,117 per prescription. Pharmacies were paid $70,215,817 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Wegovy®, at about $1,303.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what TennCare finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, TennCare. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What TennCare paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what TennCare paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	at least 19,193¹	31%	$20,434,886	$20,532,861	$1,065
tirzepatideMounjaro®	Fee-for-service	at least 9,465⁷	15%	$10,022,599	$10,170,509	$1,059
semaglutideWegovy®	Fee-for-service	at least 19,383¹³	31%	$25,260,424	$25,491,424	$1,303
semaglutideOzempic®	Fee-for-service	at least 13,416¹⁹	22%	$13,234,391	$13,402,917	$986
semaglutideRybelsus®	Fee-for-service	422²⁵	<1%	$415,734	$420,766	$985
liraglutideSaxenda®	Fee-for-service	34³¹	<1%	$32,377	$32,392	$952
liraglutideVictoza®	Fee-for-service	67³⁷	<1%	$41,352	$41,441	$617
liraglutideliraglutide (generic)	Fee-for-service	at least 291⁴³	<1%	$123,196	$123,507	$423

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 523 against 4,204. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 50.9 to 51.0 prescriptions per thousand people enrolled in TennCare, on an average of 1,224,155 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 6 of the 168 product-quarters it holds a row for here, which is 4 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus®, Saxenda® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether TennCare pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what TennCare paid for each product, quarter by quarter

Prescriptions TennCare paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable⁴Withheld1 of 1 product codes withheld	at least 43 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld³At least$44,252 paid	at least 81 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³At least$83,389 paid	at least 100 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³At least$102,639 paid	at least 141 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³At least$144,507 paid	at least 142 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$149,374 paid	at least 245 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$259,221 paid	at least 2,269 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$2,395,607 paid	at least 11,374 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$12,005,522 paid	at least 19,193 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$20,434,886 paid
tirzepatideMounjaro®range 2,971 to 3,249	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	at least 102 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$95,844 paid	at least 559 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$525,517 paid	at least 1,841 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$1,781,705 paid	at least 2,802 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$2,727,988 paid	2,971 paid prescriptions in the quarter (2023Q3)¹⁰Count$2,891,218 paid	3,249 paid prescriptions in the quarter (2023Q4)¹⁰Count$3,169,513 paid	at least 3,297 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$3,347,949 paid	at least 3,402 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$3,477,937 paid	at least 4,402 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$4,527,704 paid	at least 5,474 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$5,623,623 paid	at least 5,858 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$6,062,248 paid	at least 7,314 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁸At least$7,590,626 paid	at least 8,213 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$8,531,050 paid	at least 9,155 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$9,495,537 paid	at least 9,465 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$10,022,599 paid
semaglutideWegovy®range 443 to 14,301	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld5 of 5 product codes withheld	at least 12 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld¹⁷At least$15,667 paid	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹⁷Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable¹⁷Withheld3 of 3 product codes withheld	at least 228 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁶At least$295,420 paid	800 paid prescriptions in the quarter (2023Q2)¹⁶Count$1,035,270 paid	at least 552 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁶At least$720,408 paid	443 paid prescriptions in the quarter (2023Q4)¹⁶Count$576,390 paid	479 paid prescriptions in the quarter (2024Q1)¹⁵Count$619,716 paid	945 paid prescriptions in the quarter (2024Q2)¹⁵Count$1,224,770 paid	1,665 paid prescriptions in the quarter (2024Q3)¹⁵Count$2,181,830 paid	2,582 paid prescriptions in the quarter (2024Q4)¹⁵Count$3,361,691 paid	2,836 paid prescriptions in the quarter (2025Q1)¹⁴Count$3,703,570 paid	3,295 paid prescriptions in the quarter (2025Q2)¹⁴Count$4,311,134 paid	5,804 paid prescriptions in the quarter (2025Q3)¹⁴Count$7,596,417 paid	14,301 paid prescriptions in the quarter (2025Q4)¹⁴Count$18,716,984 paid	at least 19,383 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$25,260,424 paid
semaglutideOzempic®	at least 1,421 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$1,131,854 paid	at least 1,666 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$1,352,527 paid	at least 2,303 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$1,885,601 paid	at least 3,712 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$3,034,142 paid	at least 4,759 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$4,042,824 paid	at least 7,655 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$6,542,847 paid	at least 10,584 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$9,043,933 paid	at least 11,195 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$9,606,641 paid	at least 12,919 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$11,496,320 paid	at least 15,991 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$14,391,520 paid	at least 15,916 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$14,323,262 paid	at least 13,744 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$12,375,327 paid	at least 14,017 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$12,963,838 paid	at least 14,387 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$13,419,982 paid	at least 14,484 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$13,553,917 paid	at least 14,878 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$13,946,207 paid	at least 14,277 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$13,675,506 paid	at least 14,981 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$14,447,733 paid	at least 14,690 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$14,185,797 paid	at least 14,202 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$13,734,012 paid	at least 13,416 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹⁹At least$13,234,391 paid
semaglutideRybelsus®range 154 to 652, down 6 on the quarter before	154 paid prescriptions in the quarter (2021Q1)³⁰Count$116,690 paid	236 paid prescriptions in the quarter (2021Q2)³⁰Count$178,294 paid	322 paid prescriptions in the quarter (2021Q3)³⁰Count$253,803 paid	at least 432 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$346,144 paid	450 paid prescriptions in the quarter (2022Q1)²⁹Count$378,075 paid	652 paid prescriptions in the quarter (2022Q2)²⁹Count$548,172 paid	at least 844 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$704,919 paid	at least 861 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$723,343 paid	at least 983 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$867,697 paid	at least 948 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$844,164 paid	at least 762 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$680,678 paid	at least 698 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$623,994 paid	at least 622 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$574,010 paid	645 paid prescriptions in the quarter (2024Q2)²⁷Count$599,888 paid	606 paid prescriptions in the quarter (2024Q3)²⁷Count$569,460 paid	598 paid prescriptions in the quarter (2024Q4)²⁷Count$561,705 paid	516 paid prescriptions in the quarter (2025Q1)²⁶Count$493,004 paid	508 paid prescriptions in the quarter (2025Q2)²⁶Count$488,922 paid	491 paid prescriptions in the quarter (2025Q3)²⁶Count$474,330 paid	428 paid prescriptions in the quarter (2025Q4)²⁶Count$415,725 paid	422 paid prescriptions in the quarter (2026Q1)²⁵Count$415,734 paid
liraglutideSaxenda®range 27 to 493, up 7 on the quarter before	28 paid prescriptions in the quarter (2021Q1)³⁶Count$31,259 paid	118 paid prescriptions in the quarter (2021Q2)³⁶Count$140,501 paid	201 paid prescriptions in the quarter (2021Q3)³⁶Count$246,709 paid	303 paid prescriptions in the quarter (2021Q4)³⁶Count$367,830 paid	223 paid prescriptions in the quarter (2022Q1)³⁵Count$274,411 paid	267 paid prescriptions in the quarter (2022Q2)³⁵Count$313,644 paid	386 paid prescriptions in the quarter (2022Q3)³⁵Count$459,681 paid	469 paid prescriptions in the quarter (2022Q4)³⁵Count$547,041 paid	493 paid prescriptions in the quarter (2023Q1)³⁴Count$583,559 paid	at least 417 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld³⁴At least$484,140 paid	324 paid prescriptions in the quarter (2023Q3)³⁴Count$330,719 paid	146 paid prescriptions in the quarter (2023Q4)³⁴Count$158,031 paid	71 paid prescriptions in the quarter (2024Q1)³³Count$77,691 paid	146 paid prescriptions in the quarter (2024Q2)³³Count$160,429 paid	171 paid prescriptions in the quarter (2024Q3)³³Count$186,511 paid	189 paid prescriptions in the quarter (2024Q4)³³Count$206,370 paid	155 paid prescriptions in the quarter (2025Q1)³²Count$168,114 paid	172 paid prescriptions in the quarter (2025Q2)³²Count$190,173 paid	104 paid prescriptions in the quarter (2025Q3)³²Count$114,297 paid	27 paid prescriptions in the quarter (2025Q4)³²Count$32,244 paid	34 paid prescriptions in the quarter (2026Q1)³¹Count$32,377 paid
liraglutideVictoza®range 49 to 4,650, up 5 on the quarter before	4,022 paid prescriptions in the quarter (2021Q1)⁴²Count$3,336,861 paid	4,232 paid prescriptions in the quarter (2021Q2)⁴²Count$3,553,402 paid	4,350 paid prescriptions in the quarter (2021Q3)⁴²Count$3,662,899 paid	4,650 paid prescriptions in the quarter (2021Q4)⁴²Count$3,899,070 paid	3,691 paid prescriptions in the quarter (2022Q1)⁴¹Count$3,203,281 paid	3,567 paid prescriptions in the quarter (2022Q2)⁴¹Count$3,132,298 paid	3,530 paid prescriptions in the quarter (2022Q3)⁴¹Count$3,094,697 paid	2,985 paid prescriptions in the quarter (2022Q4)⁴¹Count$2,650,330 paid	2,908 paid prescriptions in the quarter (2023Q1)⁴⁰Count$2,635,753 paid	2,587 paid prescriptions in the quarter (2023Q2)⁴⁰Count$2,360,980 paid	2,219 paid prescriptions in the quarter (2023Q3)⁴⁰Count$2,020,547 paid	at least 1,912 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld⁴⁰At least$1,718,918 paid	1,480 paid prescriptions in the quarter (2024Q1)³⁹Count$1,058,521 paid	1,088 paid prescriptions in the quarter (2024Q2)³⁹Count$720,647 paid	309 paid prescriptions in the quarter (2024Q3)³⁹Count$198,173 paid	262 paid prescriptions in the quarter (2024Q4)³⁹Count$179,246 paid	102 paid prescriptions in the quarter (2025Q1)³⁸Count$66,389 paid	49 paid prescriptions in the quarter (2025Q2)³⁸Count$31,405 paid	60 paid prescriptions in the quarter (2025Q3)³⁸Count$38,350 paid	62 paid prescriptions in the quarter (2025Q4)³⁸Count$38,896 paid	67 paid prescriptions in the quarter (2026Q1)³⁷Count$41,352 paid
liraglutideliraglutide (generic)range 275 to 444	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	275 paid prescriptions in the quarter (2024Q3)⁴⁵Count$157,392 paid	366 paid prescriptions in the quarter (2024Q4)⁴⁵Count$213,110 paid	444 paid prescriptions in the quarter (2025Q1)⁴⁴Count$248,721 paid	at least 435 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$217,324 paid	at least 396 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$169,890 paid	at least 330 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$156,920 paid	at least 291 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$123,196 paid

What this page cannot tell you

Whether TennCare covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Tennessee in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, TN
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state TN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TN", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "6213"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, TN
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state TN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "5077"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, TN
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state TN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "58"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, TN
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state TN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, TN
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state TN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "product_name": "product_name like ZEPBOUND%, state TN, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, TN
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state TN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "product_name": "product_name like ZEPBOUND%, state TN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, TN
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state TN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TN", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1936"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, TN
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state TN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "2010"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, TN
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state TN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1361"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, TN
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state TN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1124"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, TN
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state TN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "236"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, TN
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state TN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "product_name": "product_name like MOUNJARO%, state TN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, TN
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state TN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TN", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "5427"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, TN
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state TN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "5139"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, TN
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state TN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "877"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, TN
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state TN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "334"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, TN
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state TN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2022", "quarter": "2", "utilization_type": "FFSU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "12"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, TN
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state TN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 1MG", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, TN
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state TN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TN", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "5171"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, TN
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state TN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2025", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "5350"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, TN
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state TN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2024", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "5345"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, TN
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state TN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2023", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 1M", "suppression_used": "false", "number_of_prescriptions": "6156"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, TN
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state TN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "5686"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, TN
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state TN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2198"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, TN
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state TN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TN", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "192"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, TN
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state TN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "249"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, TN
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state TN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "290"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, TN
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state TN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "471"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, TN
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state TN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "416"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, TN
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state TN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "194"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, TN
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state TN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TN", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "34"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, TN
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state TN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "172"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, TN
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state TN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "189"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, TN
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state TN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "493"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, TN
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state TN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "469"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, TN
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state TN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "false", "number_of_prescriptions": "303"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, TN
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state TN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TN", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "36"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, TN
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state TN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "53"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, TN
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state TN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "866"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, TN
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state TN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1734"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, TN
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state TN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2022", "quarter": "2", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "2157"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, TN
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state TN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2021", "quarter": "4", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "2644"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, TN
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state TN, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "TN", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "95"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, TN
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state TN, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "201"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, TN
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state TN, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "219"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, TN
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state TN, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "product_name": "product_name like LIRAGLUTID%, state TN, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, TN
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state TN, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "product_name": "product_name like LIRAGLUTID%, state TN, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, TN
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state TN, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "TN", "product_name": "product_name like LIRAGLUTID%, state TN, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 42 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 6 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean TennCare covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.